Phreesia Shares Slide on Conservative Sales Outlook

Dow Jones12-10
 

By Katherine Hamilton

 

Phreesia shares fell after the healthcare company shared a conservative outlook.

The stock slid 21% on Tuesday, at one point touching a 52-week low of $15.41. Shares are down 37% this year.

Phreesia, which automates patient check-in at healthcare facilities, on Monday adjusted its revenue outlook for fiscal 2026 to between $479 million and $481 million.

The new outlook includes a $7.5 million sales bump from Phreesia's acquisition of AccessOne, which closed in November.

Excluding the boost from AccessOne, the range would be $471.5 million to $473.5 million, which is lower than the previous revenue range the company provided. In September, Phreesia was guiding for $472 million to $482 million, a range that did not include any impact from AccessOne.

Phreesia, based in Wilmington, Del., said it expects 14% to 16% revenue growth in fiscal 2027, about 6.5% of which will come from AccessOne. That implies 8% to 10% growth in the company's core business, according to Truist analyst Jailendra Singh.

Analysts had been projecting about 12% overall revenue growth.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

December 09, 2025 13:28 ET (18:28 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment